You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 3, 2026
Sale
Calculated transaction value
$629.37K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 31, 2026
Public filing date
Aug 3, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$517.71
Jul 31, 2026
First close after public filing
$518.68
Aug 4, 2026
30-day return after filing
-5.14%
Through Sep 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,215 shares @ $518
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000111
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$6.22M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jul 31, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 31, 2026 | $187.91K |
| United Therapeutics Corp UTHR | Sale | Jul 31, 2026 | $442.07K |
| United Therapeutics Corp UTHR Current | Sale | Jul 31, 2026 | $629.37K |
| United Therapeutics Corp UTHR | Sale | Jul 31, 2026 | $657.12K |
| United Therapeutics Corp UTHR | Sale | Jul 31, 2026 | $1.37M |
| United Therapeutics Corp UTHR | Sale | Jul 31, 2026 | $790.06K |
| United Therapeutics Corp UTHR | Sale | Jul 31, 2026 | $147.07K |
| United Therapeutics Corp UTHR | Sale | Jul 31, 2026 | $124.44K |
| United Therapeutics Corp UTHR | Exercise | Jul 31, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Jul 31, 2026 | $585.7K |